Toutes les informations sur:

Nom	Cancer Research Horizons Limited
Adresse	2 Redman Place London E20 1JQ
VAT ID (Numéro de TVA)	no VAT ID available
Société Numéro de Registre	01662284 Show on Companies House
Accounts	dormant last accounts made up to 31 mars 2022
Activité (Code NAF)	72110 - Recherche-développement en biotechnologie
Statut de Société	active
Noms Précédents	Imperial Cancer Research Technology Limited
KYC Check KYC checks will cover 240 countries and 40 languages for both corporates and individuals: PEP - Any individual that is considered a Politically Exposed Person, from Head of State to Members of Parliament, Members of the Board of State Owned Enterprises or Ambassadors and individuals representing their countries interests abroad. Sanction - Any individual or entity that is (or was) subject to sanctions by either the European Union, the United Nations, the United States Office of Foreign Assets Control and State Department and Her Majesty’s Treasury in the United Kingdom. Financial Regulator - Any individual or entity that has been fined or in some other way subject to action by any financial regulatory body. Law Enforcement - Any individual or entity that has been named in official documentation from Law Enforcement bodies such as the Police or any other agency such as Interpol or the FBI. Also those individuals and entities cited in Court and legal documents of that nature. Adverse Media - Any individual or entity that has been reported in global newspapers, news sites or other media as being involved in financial crime. Other country specific datasets	KYC / PEP / AML request

This data is incorrect?
Source: Company Register: Companies House (companieshouse.gov.uk)

go to our Search Engine

Quick access

Persons with Significant Control
Officers
Similar VAT Registered Companies

Persons with Significant Control (2)

Source: Companies House

GB Cancer Research Technology Limited Status: Active Notified: 01/08/2022 Companies House Number: 01626049 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

GB Cancer Research Uk Status: Ceased Notified: 06/04/2016 Ceased: 01/08/2022 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

Significant influence or control

Officers (2)

Source: Companies House

Fairfield, Gillian Amanda London, England Status: Active Notified: 28/09/2021 Date of Birth: 06/1971 Occupation: Director And Company Secretary Role: Director Country of Residence: England Nationality: British

Fairfield, Gillian Amanda London, England Status: Active Notified: 28/09/2021 Role: Secretary

Toutes les informations sur:

Cancer Research Horizons Limited

Quick access

Persons with Significant Control (2)

Officers (2)